SGIOF.US Shionogi & Co. Ltd

Healthcare Pharmaceuticals USA Stocks
19.39 USD
Close of Nov 17, 2026
14.67 25.07
Market cap
USD 16.5B
P/E
10.8x
P/B
1.51x
ROE
13.6%
Dividend yield
2.50%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is SGIOF.US undervalued?

Graham number
Price19.39
Graham value22.81
Discount15.0%

SGIOF.US trades 15.0% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shionogi & Co. Ltd fundamental analysis

No fundamental analysis for Shionogi & Co. Ltd yet.

Shionogi & Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shionogi & Co. Ltd

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and busines…

Full company profile